Achievements in diagnosis and treatment of hepatocellular carcinoma: case report and review
- Authors: Chernobrovkina T.Y.1, Yankovskaya Y.D1, Litvinova O.S1, Oganesyan A.P1
-
Affiliations:
- N.I. Pirogov Russian National Research Medical University
- Issue: Vol 21, No 2 (2016)
- Pages: 103-110
- Section: Articles
- URL: https://journals.rcsi.science/1560-9529/article/view/40915
- DOI: https://doi.org/10.17816/EID40915
- ID: 40915
Cite item
Full Text
Abstract
Full Text
##article.viewOnOriginalSite##About the authors
Tatyana Ya. Chernobrovkina
N.I. Pirogov Russian National Research Medical University
Email: tanyura541@mail.ru
MD, PhD, Associate professor of the Department Infectious Diseases and Epidemiology of infectious disease and phthisiopulmonology 1, Ostrovityanova Str., Moscow, Russian Federation, 117997
Ya. D Yankovskaya
N.I. Pirogov Russian National Research Medical University
Email: yanina.yankowskaya@gmail.com
ассистент каф. инфекционных болезней и эпидемиологии РНИМУ им. Н.И. Пирогова 1, Ostrovityanova Str., Moscow, Russian Federation, 117997
O. S Litvinova
N.I. Pirogov Russian National Research Medical University
Email: litvinovaol@yandex.ru
ассистент каф. инфекционных болезней и эпидемиологии РНИМУ им. Н.И. Пирогова 1, Ostrovityanova Str., Moscow, Russian Federation, 117997
A. P Oganesyan
N.I. Pirogov Russian National Research Medical University
Email: ani101192@mail.ru
субординатор каф. онкологии и лучевой терапии РНИМУ им. Н.И. Пирогова 1, Ostrovityanova Str., Moscow, Russian Federation, 117997
References
- Хазанов А.И. Гепатоцеллюлярная карцинома. В кн.: Гастроэнтерология и гепатология. М.; 2011: 759-66.
- Маев И.В., Дичева Д.Т., Жиляев Е.В., Березутская О.Е., Биткова Е.Н. Трудности диагностики гепатоцеллюлярной карциномы. Consilium Medicum. 2010; 8: 63-6.
- Сторожаков Г.И., Эттингер О.А., Косюра С.Д., Геттуева А.А., Лепков С.В. Влияние вирусного гепатита В и С на течение и прогноз гепатоцеллюлярной карциномы. Лечебное дело. 2012; 2: 15-9.
- Montalto G., Cervello M., Giannitrapani L., Dantona E., Terranova A., Castagnetta L. Epidemiology, risk factors, and natural history of hepatocellular carcinoma. Ann. N. Y. Acad. Sci. 2002; 963: 13-20.
- Beasley R., Hwang L., Lin C., Chien C.S. Hepatocellular carcinoma and hepatitis B virus: a prospective study of 22 707 men in Taiwan. Lancet. 1981; 221: 1129-33.
- Beasley R. Hepatitis B virus. The major etiology of hepatocellular carcinoma. Cancer. 1988; 61: 1942-56.
- Yano M., Kumada H., Kage M., Ikeda K., Shimamatsu K., Inone O. et al. The long-term pathological evolution of chronic hepatitis C. Hepatology. 1996; 23: 1334-40.
- Degos F., Christidis C., Ganne-Carrie N., Farmachidi J., Degott C., Guettier C. et al. Hepatitis C virus related cirrhosis: time to occurrence of hepatocellular carcinoma and death. Gut. 2000; 47: 131-6.
- Sangiovanni A., Prati G., Fasani P., Ronchi G., Romeo R., Manini M. et al. The natural history of compensated cirrhosis due to hepatitis C virus: a 17-year cohort study of 214 patients. Hepatology. 2006; 43: 1303-10.
- Bralet M.P. Hepatocellular carcinoma occurring in nonfibrotic liver: epidemiologic and histopathologic analysis of 80 French cases. Hepatology. 2000; 32: 200-4.
- Shiratori Y., Shiina S., Imamura M. Characteristic difference of hepatocellular carcinoma between hepatitis B- and C-viral infection in Japan. Hepatology. 1995; 22: 1027-33.
- Fattovich G., Pantalena M., Zagni I., Realdi G., Schalm S., Christensen E. Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients. Am. J. Gastroenterol. 2002; 97: 2886-95.
- Okuda H., Obata H., Motoike Y., Hisamitsu T. Clinicopathological features of hepatocellular carcinoma-comparison of hepatitis B seropositive and seronegative patients. Hepatogastroenterology. 1984; 31: 64-8.
- Kew M.C. Hepatitis viruses (other than hepatitis B and C viruses) as causes of hepatocellular carcinoma: an update. J. Viral. Hepat. 2012; 20: 345-9.
- Абдурахманов Д.Т. Хронический гепатит В и D. М.: ГЭОТАР-Медиа; 2010.
- Farci P., Niro G. Clinical Features of Hepatitis D. Semin. Liver Dis. 2012; 32: 228-36.
- Fattovich G., Giustina V., Christensen E., Pantalena M., Zagni I., Realdi G. et.al. Influence of hepatitis Delta virus infection on morbidity and mortality in compensated cirrhosis type B. Gut. 2000; 46: 420-6.
- Negro F., Papotti M., Taraglio S., Rubbia K., Brandt L., Giostra E. et al. Relationship between hepatocyte proliferation and hepatitis delta virus replication in neoplastic and non-neoplastic liver tissues. J. Viral. Hepat. 1997; 4: 93-8.
- McMahon B.J., Bulkow L., Harpster A., Snowball M., Lanier A. et al. Screening for hepatocellular carcinoma in Alaska natives infected with chronic hepatitis B: a 16-year population-based study. Hepatology. 2000; 32: 842-6.
- Zhang B.H., Yang B.H., Tang Z.Y. Randomized controlled trial of screening for hepatocellular carcinoma. J. Cancer Res. Clin. Oncol. 2004; 130: 417-22.
- Bergstrand C.G., Czar B. Demonstration of a new protein fraction in serum from the human fetus. Scand. J. Clin. Lab. Invest. 1956; 8 (2): 174.
- Abelev G.I. Production of embryonal serum alpha-globulin by hepatomas: review of experimental and clinical data. Cancer Res. 1968; 28 (7): 1344-50.
- Yoshima H., Mizuochi T., Ishii M., Kobata A. Structure of the asparagine-linked sugar chains of alpha-fetoprotein purifi ed from human ascites fl uid. Cancer Res. 1980; 40 (11): 4276-81.
- Debruyne E.N., Delanghe J.R. Diagnosing and monitoring hepatocellular carcinoma with alpha fetoprotein: new aspects and applications. Clin. Chim. Acta. 2008; 395 (1-2): 19-26.
- Gorog D., Regoly-Merei J., Paku S. Alphafetoprotein expression is a potential prognostic marker in hepatocellular carcinoma. World J. Gastroenterol. 2005; 11: 5015-8.
- Van Nieuwkerk C.M., Rauws E.A., Tytgat G.N., Reeders J., Jones A., Gouma D. Diagnosis and treatment of hepatocellular carcinoma: new approaches. Ned. Tijdschr Geneeskd. 1996; 140 (17): 922-6.
- Liebman H.A., Furie B., Tong M., Blanchard R., Lo K.S., Lee S.D. et al. Des-gamma-carboxy (abnormal) prothrombin as a serum marker of primary hepatocellular carcinoma. N. Engl. J. Med. 1984; 310: 1427-31.
- Lopez J.B. Recent developments in the first detection of hepatocellular carcinoma. Clin. Biochem. Rev. 2005; 26: 65-79.
- Malaguarnera G., Giordano M., Paladina I., Berretta M., Cappellani A., Malaguarnera M. Serum markers of hepatocellular carcinoma. Dig. Dis. Sci. 2010; 55: 2744-55.
- Nakagawa T., Scki T., Shiro T., Wakabayashi M., Imamura M. et al. Clinicopathologic significance of protein induced vitamin K absence or antagonist II and alpha-fetoprotein in hepatocellular Carcinoma. Int. J. Oncol. 1999; 14: 281-6.
- Marrero J.A., Grace L.S., Wei Wei, Emick D., Conjeevaram S., Fontana R. et al. Des-gamma carboxyprothrombin can differentiate hepatocellular carcinoma from nonmalignant chronic liver disease in american patients. Hepatology. 2003; 37: 1114-21.